SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain ClinVar gnomAD ESM1b AlphaMissense REVEL FoldX Rosetta Foldetta PremPS PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation DOI
Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Score Prediction Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.2095G>AV699M
(3D Viewer)
GAPUncertain 26-33441354-G-A84.96e-6-8.869Likely Pathogenic0.484AmbiguousLikely Benign0.276Likely Benign-0.58Ambiguous0.10.29Likely Benign-0.15Likely Benign0.96Ambiguous-2.18Neutral0.994Probably Damaging0.806Possibly Damaging3.37Benign0.03Affected3.471021-2.332.06257.8-47.20.00.00.90.1XPotentially BenignThe isopropyl side chain of Val699, located on an α-helix (res. Leu685-Gln702), packs against hydrophobic residues (e.g., Leu703, Leu696, Leu435, Leu439) in the inter-helix space. In the variant simulations, the thioether side chain of Met699 has similar physicochemical properties to Val699 in the WT, and thus, it is able to maintain similar interactions. Consequently, the mutation causes no apparent changes in the structure.
c.2101C>TP701S
(3D Viewer)
Likely BenignGAPUncertain 16-33441360-C-T31.86e-6-4.375Likely Benign0.221Likely BenignLikely Benign0.132Likely Benign1.33Ambiguous0.00.12Likely Benign0.73Ambiguous-0.36Likely Benign0.78Neutral0.044Benign0.025Benign3.48Benign1.00Tolerated3.4710-110.8-10.0410.1016/j.ajhg.2020.11.011
c.1714T>GW572G
(3D Viewer)
Likely PathogenicGAPUncertain 1-17.692Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.900Likely Pathogenic6.57Destabilizing0.27.57Destabilizing7.07Destabilizing1.83Destabilizing-11.98Deleterious1.000Probably Damaging1.000Probably Damaging-1.24Pathogenic0.00Affected3.3735-7-20.5-129.16195.2127.90.00.0-1.00.0XPotentially PathogenicThe introduced residue Gly572, located in an α-helix (res. Arg563-Glu578), is considerably smaller than the tryptophan it replaced. The indole ring of the Trp572 side chain lies in a hydrophobic inter-helix space, where it makes extensive hydrophobic interactions with nearby residues such as Met470, Phe569, Leu588, and Ile589. In the variant simulations, all these favorable packing interactions are completely removed, as the introduced residue Gly572 essentially lacks a side chain altogether. Although not observed in the simulations, the residue swap could also weaken the integrity of the helix (res. Arg563-Glu578), as glycine is known as an “α-helix breaker.” Overall, the residue swap is highly likely to cause critical protein folding problems that are underestimated based on the effects seen in the variant simulations.
c.2111G>CS704T
(3D Viewer)
Likely BenignGAPUncertain 1-4.930Likely Benign0.265Likely BenignLikely Benign0.071Likely Benign0.80Ambiguous0.00.15Likely Benign0.48Likely Benign0.29Likely Benign-1.72Neutral0.525Possibly Damaging0.107Benign3.45Benign0.07Tolerated3.4710110.114.03201.7-18.00.00.0-0.20.7XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. Similarly, in the variant simulations, the hydroxyl side chain of Thr704 forms hydrogen bonds with the amide groups of Ala707 and Leu708. Thus, the residue swap does not cause any apparent structural change.
c.2113A>CK705Q
(3D Viewer)
Likely BenignGAPUncertain 16-33441372-A-C16.20e-7-5.787Likely Benign0.436AmbiguousLikely Benign0.142Likely Benign-0.10Likely Benign0.00.33Likely Benign0.12Likely Benign-0.02Likely Benign-0.24Neutral0.997Probably Damaging0.969Probably Damaging3.42Benign0.78Tolerated3.4710110.4-0.04
c.2131C>GL711V
(3D Viewer)
Likely PathogenicGAPUncertain16-33441596-C-G16.20e-7-10.045Likely Pathogenic0.709Likely PathogenicLikely Benign0.170Likely Benign3.48Destabilizing0.12.22Destabilizing2.85Destabilizing1.40Destabilizing-2.59Deleterious0.992Probably Damaging0.970Probably Damaging3.34Benign0.00Affected3.509120.4-14.03
c.2186A>GN729S
(3D Viewer)
Likely BenignGAPUncertain 1-1.578Likely Benign0.066Likely BenignLikely Benign0.063Likely Benign0.14Likely Benign0.11.34Ambiguous0.74Ambiguous-0.36Likely Benign-0.42Neutral0.221Benign0.027Benign3.38Benign0.93Tolerated3.597112.7-27.03
c.218G>AR73KLikely BenignUncertain 16-33425826-G-A21.24e-6-4.033Likely Benign0.151Likely BenignLikely Benign0.077Likely Benign-0.46Neutral0.053Benign0.007Benign4.14Benign0.00Affected4.321230.6-28.01
c.2195G>CR732TUncertain 1-8.545Likely Pathogenic0.434AmbiguousLikely Benign0.075Likely Benign-1.96Neutral0.999Probably Damaging0.892Possibly Damaging2.59Benign0.12Tolerated3.597-1-13.8-55.08
c.2200C>TP734SLikely BenignUncertain 26-33441665-C-T21.24e-6-4.291Likely Benign0.077Likely BenignLikely Benign0.030Likely Benign-2.44Neutral0.344Benign0.048Benign2.77Benign0.11Tolerated3.6461-10.8-10.0410.1016/j.ajhg.2020.11.011
c.2207G>AR736HLikely BenignUncertain 16-33441672-G-A63.72e-6-5.409Likely Benign0.067Likely BenignLikely Benign0.029Likely Benign-0.12Neutral0.004Benign0.001Benign2.50Benign0.00Affected4.073201.3-19.05
c.2210A>CQ737PLikely BenignUncertain 1-2.407Likely Benign0.054Likely BenignLikely Benign0.154Likely Benign-1.22Neutral0.005Benign0.013Benign2.78Benign0.04Affected4.073-101.9-31.01
c.2215G>CE739QLikely BenignUncertain 1-2.846Likely Benign0.161Likely BenignLikely Benign0.071Likely Benign-1.06Neutral0.801Possibly Damaging0.339Benign2.57Benign0.00Affected4.322220.0-0.98
c.2216A>TE739VLikely BenignUncertain 1-3.136Likely Benign0.274Likely BenignLikely Benign0.085Likely Benign-1.86Neutral0.891Possibly Damaging0.575Possibly Damaging2.47Pathogenic0.00Affected4.322-2-27.7-29.98
c.1741C>TR581W
(3D Viewer)
Likely PathogenicGAPUncertain 2-12.855Likely Pathogenic0.920Likely PathogenicAmbiguous0.678Likely Pathogenic1.32Ambiguous0.1-0.32Likely Benign0.50Ambiguous0.68Ambiguous-6.79Deleterious1.000Probably Damaging0.997Probably Damaging-1.37Pathogenic0.01Affected3.37342-33.630.03257.836.00.10.10.10.3XXPotentially PathogenicArg581 is located on a short α-α loop between two α helices (res. Arg563-Glu578 and res. Glu582-Ser604). In the WT simulations, the guanidinium group of Arg581 forms salt bridges with the carboxylate groups of Asp583 within the same helix, as well as with Glu478 and/or Glu480 in a slightly α-helical loop (res. Glu478-Thr488) preceding another α helix (res. Ala461-Phe476).In the variant simulations, the neutral indole ring of the Trp581 side chain cannot form any of these salt bridges. Instead, it packs hydrophobically against Met477 and Ile587 without forming any direct hydrogen bonds. The tendency of the loop (res. Asp477-Thr488) to acquire an α-helical structure seems to marginally increase, potentially due to Trp581's inability to coordinate stable hydrogen bonds with the loop residues (e.g., Glu478-Arg581 salt bridge). Additionally, the residue swap could weaken the tertiary structure assembly and negatively affect the overall protein folding process.
c.2217G>CE739DLikely BenignUncertain 1-3.369Likely Benign0.062Likely BenignLikely Benign0.097Likely Benign-0.49Neutral0.002Benign0.005Benign2.59Benign0.00Affected320.0-14.03
c.2218C>TR740WUncertain 26-33441683-C-T63.72e-6-8.561Likely Pathogenic0.168Likely BenignLikely Benign0.180Likely Benign-3.09Deleterious1.000Probably Damaging0.938Probably Damaging2.52Benign0.01Affected4.3222-33.630.03
c.2219G>AR740QLikely BenignUncertain 16-33441684-G-A42.48e-6-5.195Likely Benign0.078Likely BenignLikely Benign0.102Likely Benign-0.67Neutral0.999Probably Damaging0.881Possibly Damaging2.60Benign0.08Tolerated4.322111.0-28.06
c.221G>AS74NLikely BenignUncertain 16-33425829-G-A53.10e-6-5.156Likely Benign0.112Likely BenignLikely Benign0.031Likely Benign-0.89Neutral0.043Benign0.007Benign4.09Benign0.00Affected4.32111-2.727.03
c.2221C>TP741SLikely BenignUncertain 26-33441686-C-T31.86e-6-3.700Likely Benign0.063Likely BenignLikely Benign0.076Likely Benign-0.27Neutral0.270Benign0.136Benign2.92Benign0.00Affected4.3221-10.8-10.0410.1016/j.ajhg.2020.11.011
c.2224C>TR742WLikely BenignUncertain 16-33441689-C-T63.72e-6-7.725In-Between0.133Likely BenignLikely Benign0.079Likely Benign-1.71Neutral0.992Probably Damaging0.684Possibly Damaging2.66Benign0.01Affected4.322-323.630.03
c.2225G>AR742QLikely BenignUncertain 26-33441690-G-A241.49e-5-4.090Likely Benign0.068Likely BenignLikely Benign0.054Likely Benign-0.19Neutral0.032Benign0.007Benign2.73Benign0.07Tolerated4.322111.0-28.06
c.2239G>CV747LLikely BenignUncertain 16-33441704-G-C21.24e-6-2.790Likely Benign0.096Likely BenignLikely Benign0.047Likely Benign-0.52Neutral0.065Benign0.033Benign2.67Benign0.00Affected4.32221-0.414.03
c.1752C>GI584M
(3D Viewer)
Likely PathogenicGAPUncertain 26-33440804-C-G16.20e-7-10.119Likely Pathogenic0.419AmbiguousLikely Benign0.478Likely Benign0.11Likely Benign0.10.46Likely Benign0.29Likely Benign1.16Destabilizing-2.62Deleterious0.983Probably Damaging0.925Probably Damaging-1.25Pathogenic0.12Tolerated3.373421-2.618.03247.5-20.3-0.10.3-0.10.1XPotentially BenignA hydrophobic residue, Ile584, located in an α helix (res. Glu582-Met603), is swapped for another hydrophobic residue, Met584. The sec-butyl hydrocarbon side chain of Ile584 packs hydrophobically with residues in an inter-helix hydrophobic space (e.g., Leu588, Met477, Val473, and Ile483).In the variant simulations, the thioether hydrophobic side chain of Met584 maintains similar interactions as Ile584 in the WT, as it is roughly the same size and fits well within the hydrophobic space. Thus, the residue swap does not appear to cause any negative effects on the protein structure.
c.1760G>CR587T
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.697Likely Pathogenic0.784Likely PathogenicLikely Benign0.603Likely Pathogenic1.14Ambiguous0.20.74Ambiguous0.94Ambiguous0.98Ambiguous-4.71Deleterious0.998Probably Damaging0.847Possibly Damaging-1.19Pathogenic0.08Tolerated3.3735-1-13.8-55.08227.287.40.00.00.50.1XPotentially PathogenicThe guanidinium group of Arg587, located on an α helix (res. Glu582-Met603), is constantly rotating and breaking/forming multiple hydrogen bonds and/or salt bridges at the surface intersection of α helices in the WT simulations. The positively charged Arg587 side chain can form a salt bridge with either the carboxylate group of Asp583 or Asp586 in the same helix, or with Glu480 on the opposing short helical loop structure (res. Glu480-Leu482).Importantly, the Arg587 side chain also hydrogen bonds with the backbone carbonyl groups of Ala634 and Asn635, as well as the carboxamide group of Asn635 at the end of another α helix (res. Asp616-Phe636). However, in the variant simulations, the neutral hydroxyl group of the Thr587 side chain is unable to form these salt bridges. Due to its smaller size, it also does not form the hydrogen bonds that the Arg587 side chain could. Instead, the hydroxyl group of Thr587 hydrogen bonds with the backbone carbonyl group of Asp583, which could weaken the integrity of the α helix, although this is not observed in the simulations.Overall, the residue swap could weaken the tertiary structure assembly and negatively affect the overall protein folding process.
c.1767C>GI589M
(3D Viewer)
Likely PathogenicGAPUncertain 1-12.225Likely Pathogenic0.926Likely PathogenicAmbiguous0.830Likely Pathogenic0.74Ambiguous0.21.54Ambiguous1.14Ambiguous1.33Destabilizing-2.99Deleterious1.000Probably Damaging1.000Probably Damaging-1.94Pathogenic0.00Affected3.373521-2.618.03267.6-24.50.00.0-0.10.1XPotentially BenignA hydrophobic residue, Ile589, located in an α helix (res. Glu582-Met603), is swapped for another hydrophobic residue, methionine. The sec-butyl hydrocarbon side chain of Ile589 packs favourably with multiple residues in the inter-helix hydrophobic space (e.g., Phe569, Ile667, and Leu664).Although the S-methyl thioether group of the Met589 side chain in the variant is longer than the branched side chain of isoleucine, it stacks favourably with the aromatic phenol ring. Additionally, the polar sulphur atom forms a weak hydrogen bond with the guanidinium group of Arg573, which in turn forms a salt bridge with the carboxylate group of Asp586.Overall, the hydrophobic packing in the inter-helix space does not appear to be disrupted in the variant simulations.
c.2249G>AG750EUncertain 1-2.618Likely Benign0.413AmbiguousLikely Benign0.146Likely Benign-2.27Neutral1.000Probably Damaging0.982Probably Damaging2.49Pathogenic0.01Affected3.9950-2-3.172.06
c.2255C>TS752LLikely BenignUncertain 26-33441720-C-T63.72e-6-3.386Likely Benign0.182Likely BenignLikely Benign0.195Likely Benign-2.09Neutral0.993Probably Damaging0.641Possibly Damaging1.51Pathogenic0.01Affected3.995-3-24.626.08
c.2270G>CG757ALikely BenignUncertain 1-2.626Likely Benign0.091Likely BenignLikely Benign0.066Likely Benign-0.45Neutral0.267Benign0.127Benign2.73Benign0.35Tolerated102.214.03
c.1771G>CA591P
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.479Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.404Likely Benign3.78Destabilizing0.37.29Destabilizing5.54Destabilizing1.45Destabilizing-4.41Deleterious0.995Probably Damaging0.853Possibly Damaging3.35Benign0.01Affected3.37351-1-3.426.04191.5-10.10.20.10.40.1XPotentially PathogenicThe methyl group of the Ala591 side chain, located in the middle of an α helix (res. Glu582-Met603), packs against hydrophobic residues (e.g., Ile483, Phe484) of an opposing partially helical loop (res. Phe476-Asn487).In the variant simulations, Pro591 lacks a free backbone amide group and, therefore, cannot form a hydrogen bond with the backbone carbonyl of Arg587 as Ala591 does in the WT. This notably weakens the α helix integrity and compromises the continuity of the helix. In reality, the effect on the structure during protein folding could be more severe.
c.1778T>AL593H
(3D Viewer)
Likely PathogenicGAPUncertain 1-16.504Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.812Likely Pathogenic2.52Destabilizing0.22.32Destabilizing2.42Destabilizing2.75Destabilizing-6.77Deleterious1.000Probably Damaging1.000Probably Damaging2.77Benign0.00Affected3.3735-2-3-7.023.98222.020.70.00.00.20.0XXPotentially PathogenicThe iso-propyl side chain of Leu593, located in an α helix (res. Glu582-Met603), packs favourably with multiple hydrophobic residues in the inter-helix space (e.g., Leu598, Ile589, Phe594, Phe561).In the variant simulations, His593 retains a similar packing arrangement via its aromatic imidazole ring. However, the polar nitrogen atoms introduce hydrogen bond donors and acceptors into the previously hydrophobic space. The epsilon protonated nitrogen of His593 forms a stable hydrogen bond with the phenol group of the Tyr505 side chain in an α helix (res. Gln503-Tyr518).While the residue swap could affect the tertiary assembly and the underlying protein folding process, it is difficult to determine if the mutation would be tolerated based solely on the variant simulations.
c.2275A>CM759LLikely BenignUncertain 16-33441740-A-C21.24e-6-2.431Likely Benign0.093Likely BenignLikely Benign0.048Likely Benign-0.53Neutral0.002Benign0.005Benign2.84Benign1.00Tolerated3.995421.9-18.03
c.2277G>AM759ILikely BenignUncertain 16-33441742-G-A16.20e-7-4.058Likely Benign0.393AmbiguousLikely Benign0.075Likely Benign-0.88Neutral0.454Possibly Damaging0.192Benign2.83Benign0.34Tolerated3.995122.6-18.03
c.227C>GS76CLikely BenignUncertain 16-33425835-C-G21.24e-6-5.408Likely Benign0.100Likely BenignLikely Benign0.076Likely Benign-1.78Neutral0.992Probably Damaging0.869Possibly Damaging3.71Benign0.00Affected4.3210-13.316.06
c.2282G>AR761QLikely BenignUncertain 16-33441747-G-A116.81e-6-4.187Likely Benign0.202Likely BenignLikely Benign0.191Likely Benign-0.63Neutral0.996Probably Damaging0.878Possibly Damaging2.75Benign0.40Tolerated3.995111.0-28.06
c.2282G>CR761PLikely BenignUncertain 36-33441747-G-C16.20e-7-5.091Likely Benign0.640Likely PathogenicLikely Benign0.201Likely Benign-1.89Neutral0.999Probably Damaging0.968Probably Damaging2.69Benign0.38Tolerated3.9950-22.9-59.07
c.2294G>AS765NLikely BenignUncertain 1-5.098Likely Benign0.378AmbiguousLikely Benign0.094Likely Benign-0.94Neutral0.985Probably Damaging0.950Probably Damaging4.11Benign0.06Tolerated3.64611-2.727.03
c.2299A>GI767VLikely BenignUncertain 1-2.791Likely Benign0.064Likely BenignLikely Benign0.096Likely Benign0.10Neutral0.072Benign0.029Benign4.21Benign1.00Tolerated3.64643-0.3-14.03
c.1787G>TR596L
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.197Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.756Likely Pathogenic1.51Ambiguous0.3-0.58Ambiguous0.47Likely Benign-0.02Likely Benign-6.97Deleterious1.000Probably Damaging1.000Probably Damaging2.45Pathogenic0.00Affected3.3735-3-28.3-43.03234.263.4-0.10.0-0.50.6XXPotentially PathogenicThe guanidinium group of Arg596, located in an α helix (res. Glu582-Met603), forms a salt bridge with the carboxylate group of Glu495 from another α helix (res. Leu489-Glu519). In the WT simulations, the side chain of Arg596 hydrogen bonds with the backbone carbonyl groups of Asn487, Glu486, Arg485, and Phe484. Additionally, Arg596 can hydrogen bond with the carboxamide group of the Asn487 side chain on an opposing loop that links two α helices (res. Ala461-Arg475, res. Leu489-Glu519).However, in the variant simulations, the branched hydrocarbon side chain of Leu596 cannot form any of the hydrogen bonds or salt bridges maintained by the considerably bulkier and positively charged Arg596 side chain. Instead, Leu596 packs hydrophobically with the phenyl ring of Phe484 in the linker loop or residues from the opposing helix (e.g., Ile494, Thr491).Thus, the residue swap could affect the tertiary structure assembly more profoundly than observed in the simulations. Notably, Arg596 plays a key role in positioning the aforementioned loop, which is crucial for the placement of the “arginine finger” or the Arg485 side chain during RasGTPase activation.10.1016/j.ajhg.2020.11.011
c.1802C>TA601V
(3D Viewer)
Likely PathogenicGAPUncertain 1-10.447Likely Pathogenic0.853Likely PathogenicAmbiguous0.535Likely Pathogenic1.64Ambiguous0.10.35Likely Benign1.00Ambiguous0.81Ambiguous-3.98Deleterious1.000Probably Damaging0.989Probably Damaging2.74Benign0.03Affected3.3735002.428.05228.5-45.50.00.00.40.5XPotentially BenignThe methyl side chain of Ala601, located on an α helix (res. Glu582-Met603), packs hydrophobically against other hydrophobic residues in the inter-helix space (e.g., Phe597, Leu598, Leu506, Phe608).In the variant simulations, Val601, which has similar size and physicochemical properties to alanine, resides in the inter-helix hydrophobic space in a similar manner to Ala601 in the WT, causing no apparent negative effect on the protein structure. However, the effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.2300T>CI767TLikely BenignUncertain 1-3.749Likely Benign0.252Likely BenignLikely Benign0.138Likely Benign-0.78Neutral0.625Possibly Damaging0.249Benign4.12Benign0.46Tolerated3.6460-1-5.2-12.05
c.2302G>AD768NLikely BenignUncertain 16-33442460-G-A22.57e-6-6.892Likely Benign0.453AmbiguousLikely Benign0.048Likely Benign-0.77Neutral0.106Benign0.009Benign4.07Benign0.96Tolerated3.646120.0-0.98
c.2302G>TD768YLikely PathogenicUncertain 16-33442460-G-T-9.866Likely Pathogenic0.824Likely PathogenicAmbiguous0.234Likely Benign-2.86Deleterious0.989Probably Damaging0.806Possibly Damaging4.01Benign0.07Tolerated3.646-4-32.248.09
c.2305C>TL769FLikely BenignUncertain 1-5.044Likely Benign0.146Likely BenignLikely Benign0.060Likely Benign-0.89Neutral0.925Possibly Damaging0.510Possibly Damaging3.94Benign0.02Affected20-1.034.02
c.2339C>GS780CLikely BenignUncertain 46-33442891-C-G169.94e-6-7.603In-Between0.278Likely BenignLikely Benign0.078Likely Benign-1.41Neutral0.065Benign0.043Benign2.59Benign0.10Tolerated3.646-103.316.06
c.233G>TR78LLikely BenignUncertain 1-3.389Likely Benign0.635Likely PathogenicLikely Benign0.062Likely Benign-1.59Neutral0.385Benign0.021Benign3.84Benign0.00Affected-3-28.3-43.03
c.1811C>TS604L
(3D Viewer)
Likely PathogenicGAPUncertain 16-33440863-C-T63.72e-6-14.683Likely Pathogenic0.965Likely PathogenicLikely Pathogenic0.639Likely Pathogenic-0.94Ambiguous0.1-1.24Ambiguous-1.09Ambiguous-0.31Likely Benign-5.97Deleterious1.000Probably Damaging0.991Probably Damaging3.09Benign0.00Affected3.3735-3-24.626.08234.0-49.60.00.10.30.5XXPotentially PathogenicSer604 is located in a short turn between an α helix (res. Glu582-Met603) and a short α helical section (res. Ser606-Phe608). In the WT simulations, the hydroxyl side chain of Ser604 periodically hydrogen bonds with the backbone carbonyl groups of other α helix residues (e.g., Pro600, Met603). Serine weakens the α helix secondary structure, and thus, Ser604 along with Pro605 breaks the α helix, facilitating the turn in the WT structure.In contrast, in the variant simulations, Leu604 forms a few hydrophobic interactions (e.g., Leu607, Phe608). More importantly, the helix end is more stable than with Ser604 in the WT. The residue swap could have a more profound effect on the actual folding process, for example, by preventing the bending at the α helix end, than what the simulations suggest.Moreover, Ser604 directly hydrogen bonds with Ras residues Ser65 and Ala66 in the WT SynGAP-Ras complex. The hydrophobic leucine cannot maintain these interactions with Ras at the GAP-Ras interface. Thus, the effect of the residue swap on the complex formation with the GTPase cannot be fully explored in the solvent-only simulations.
c.1813C>TP605S
(3D Viewer)
Likely PathogenicGAPUncertain 1-10.830Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.718Likely Pathogenic3.40Destabilizing0.13.34Destabilizing3.37Destabilizing1.00Destabilizing-7.96Deleterious1.000Probably Damaging1.000Probably Damaging0.70Pathogenic0.00Affected3.37351-10.8-10.04213.8-15.4-0.30.20.20.1XXPotentially PathogenicPro605 is located in a short turn between an α helix (res. Glu582-Met603) and a short α helical section (res. Ser606-Phe608). The pyrrolidine side chain of Pro605 packs hydrophobically with nearby hydrophobic residues (e.g., Ile514, Leu623, Leu610) in the inter-helix space. Additionally, proline lacks a free backbone amide group, which breaks the α helix and facilitates the turn in the WT structure.In the variant simulations, the hydroxyl side chain of Ser605 forms hydrogen bonds with the backbone carbonyl groups of Ala601 and Ile602. Importantly, the helix end is more stable than with Pro605 in the WT. Indeed, proline is a more effective secondary structure breaker compared to serine.Thus, the residue swap could have a more profound effect on the actual folding process, for example, by preventing the bending at the α helix end, than what the simulations suggest. Moreover, due to its location at the GAP-Ras interface, the residue swap could affect the GAP-Ras association.
c.1814C>GP605R
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.745Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.845Likely Pathogenic8.71Destabilizing2.56.46Destabilizing7.59Destabilizing0.92Ambiguous-8.95Deleterious1.000Probably Damaging1.000Probably Damaging0.69Pathogenic0.00Affected3.37350-2-2.959.07281.7-118.1-0.20.00.50.1XXXXPotentially PathogenicPro605 is located in a short turn between an α helix (res. Glu582-Met603) and a short α helical section (res. Ser606-Phe608). The pyrrolidine side chain of Pro605 packs hydrophobically with nearby hydrophobic residues (e.g., Ile514, Leu623, Leu610) in the inter-helix space. Additionally, proline lacks a free backbone amide group, which breaks the α helix and facilitates the turn in the WT structure.In the variant simulations, the guanidinium side chain of Arg605 is bulkier than proline, and its positively charged guanidinium group faces mostly hydrophobic residues (e.g., Ile514, Leu623, Leu610). As a result, it needs to rotate away from the hydrophobic niche. The residue swap could have a more profound effect on the actual folding process, for example, by preventing the bending at the α helix end.Moreover, due to its location at the GAP-Ras interface, the residue swap could affect the GAP-Ras association.
c.1819C>GL607V
(3D Viewer)
Likely PathogenicGAPUncertain 26-33440871-C-G21.24e-6-11.190Likely Pathogenic0.637Likely PathogenicLikely Benign0.715Likely Pathogenic1.04Ambiguous0.21.36Ambiguous1.20Ambiguous0.90Ambiguous-2.99Deleterious0.985Probably Damaging0.992Probably Damaging-1.50Pathogenic0.01Affected3.3735210.4-14.03216.328.10.10.00.90.2XPotentially BenignLeu607 is located in a short helical region (res. Ser606-Phe608) within an α-α loop connecting two α helices (res. Glu582-Met603 and res. Glu617-Asn635). In the WT simulations, the iso-butyl side chain of Leu607 does not interact with any other residues, but it could potentially interact directly with Ras due to its location at the GAP domain.In the variant simulations, Val607, which has similar size and physicochemical properties to leucine, does not cause any negative effects on the protein structure. However, due to its location at the GAP-Ras interface, the residue swap could affect the complex formation with the GTPase, but this cannot be investigated using solvent-only simulations.
c.2353C>TR785CLikely PathogenicSH3-binding motifUncertain 16-33442905-C-T291.80e-5-5.887Likely Benign0.662Likely PathogenicLikely Benign0.126Likely Benign-5.06Deleterious0.144Benign0.046Benign2.22Pathogenic0.00Affected3.646-4-37.0-53.05
c.2354G>AR785HSH3-binding motifUncertain 26-33442906-G-A42.50e-6-4.782Likely Benign0.388AmbiguousLikely Benign0.129Likely Benign-2.61Deleterious0.999Probably Damaging0.947Probably Damaging2.25Pathogenic0.01Affected3.646201.3-19.05
c.2359C>TP787SSH3-binding motifUncertain 16-33442911-C-T31.86e-6-4.203Likely Benign0.564AmbiguousLikely Benign0.221Likely Benign-3.81Deleterious1.000Probably Damaging0.999Probably Damaging2.48Pathogenic0.02Affected3.646-110.8-10.04
c.2362T>AS788TLikely BenignSH3-binding motifUncertain 26-33442914-T-A42.49e-6-4.288Likely Benign0.288Likely BenignLikely Benign0.092Likely Benign-2.25Neutral0.979Probably Damaging0.982Probably Damaging1.55Pathogenic0.02Affected3.646110.114.03
c.2369C>GT790SLikely BenignSH3-binding motifUncertain 1-3.914Likely Benign0.123Likely BenignLikely Benign0.134Likely Benign-1.83Neutral0.997Probably Damaging0.989Probably Damaging2.39Pathogenic0.33Tolerated3.64611-0.1-14.03
c.2393C>TP798LLikely BenignSH3-binding motifUncertain 26-33442945-C-T63.72e-6-5.640Likely Benign0.074Likely BenignLikely Benign0.042Likely Benign-0.86Neutral0.981Probably Damaging0.631Possibly Damaging4.21Benign0.00Affected4.321-3-35.416.04
c.2401G>AG801SLikely BenignSH3-binding motifUncertain 1-3.665Likely Benign0.087Likely BenignLikely Benign0.039Likely Benign-0.41Neutral0.009Benign0.019Benign2.76Benign0.48Tolerated4.32201-0.430.03
c.2405G>AG802DLikely BenignSH3-binding motifUncertain 16-33442957-G-A16.20e-7-5.083Likely Benign0.476AmbiguousLikely Benign0.153Likely Benign-0.38Neutral0.126Benign0.138Benign2.72Benign0.09Tolerated3.7751-1-3.158.04
c.2408A>GK803RLikely BenignSH3-binding motifUncertain 1-2.281Likely Benign0.097Likely BenignLikely Benign0.018Likely Benign-1.52Neutral0.103Benign0.038Benign2.38Pathogenic0.00Affected3.77532-0.628.01
c.2414T>CL805PSH3-binding motifUncertain 1-4.661Likely Benign0.444AmbiguousLikely Benign0.272Likely Benign-3.40Deleterious0.975Probably Damaging0.767Possibly Damaging2.36Pathogenic0.00Affected3.775-3-3-5.4-16.04
c.2420A>GY807CSH3-binding motifUncertain 16-33442972-A-G16.20e-7-7.228In-Between0.204Likely BenignLikely Benign0.243Likely Benign-3.89Deleterious0.997Probably Damaging0.934Probably Damaging2.42Pathogenic0.01Affected3.7750-23.8-60.04
c.2420A>TY807FLikely BenignSH3-binding motifUncertain 1-3.667Likely Benign0.073Likely BenignLikely Benign0.057Likely Benign0.14Neutral0.012Benign0.022Benign2.92Benign0.98Tolerated3.775734.1-16.00
c.2434C>TP812SLikely BenignSH3-binding motifUncertain 16-33442986-C-T16.20e-7-5.689Likely Benign0.456AmbiguousLikely Benign0.162Likely Benign-0.62Neutral0.999Probably Damaging0.966Probably Damaging2.89Benign0.95Tolerated4.3241-10.8-10.04
c.2435C>AP812HSH3-binding motifUncertain 26-33442987-C-A31.86e-6-7.470In-Between0.698Likely PathogenicLikely Benign0.272Likely Benign-2.81Deleterious1.000Probably Damaging0.995Probably Damaging2.68Benign0.00Affected4.3240-2-1.640.02
c.1947G>CM649I
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.361Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.449Likely Benign2.42Destabilizing0.21.96Ambiguous2.19Destabilizing1.01Destabilizing-3.99Deleterious0.672Possibly Damaging0.093Benign3.40Benign0.02Affected3.3827212.6-18.03243.721.50.00.10.00.1XPotentially BenignThe thioether side chain of Met649, located on an α helix (res. Ser641-Glu666), bridges Phe652, Phe648, and Phe639 in an inter-helix hydrophobic cavity in the WT simulations. In the variant simulations, the sec-butyl side chain of Ile649 maintains hydrophobic interactions with nearby residues, with no significant effects on the protein structure.However, methionine is known as a bridging motif for aromatic residues, and these Met-aromatic interactions are lost in the variant. Indeed, in the second variant simulation,the bridging of Phe652, Phe648 and Phe639 is completely lost. In reality, the effect could be more severe on the structure during the protein folding.
c.1966G>CE656Q
(3D Viewer)
GAPUncertain 16-33441225-G-C16.20e-7-9.145Likely Pathogenic0.766Likely PathogenicLikely Benign0.249Likely Benign-0.14Likely Benign0.0-0.81Ambiguous-0.48Likely Benign0.25Likely Benign-2.29Neutral0.980Probably Damaging0.528Possibly Damaging3.46Benign0.02Affected3.3924220.0-0.98224.31.70.00.10.10.0XPotentially BenignThe carboxylate side chain of Glu656, located on an α helix (res. Ser641-Glu666), frequently forms a hydrogen bond with the nearby residue Ser659 on the same α helix. In the variant simulations, the carboxamide side chain of Gln656 alternatively forms a hydrogen bond with either Ser659 or Glu548 on an opposing helix (res. Ala533-Val560).Although the frequent interaction between Gln656 and Glu548 may strengthen or stabilize the tertiary structure assembly, the effect is likely to be marginal.
c.1998G>CE666D
(3D Viewer)
Likely PathogenicGAPUncertain 1-8.820Likely Pathogenic0.704Likely PathogenicLikely Benign0.197Likely Benign0.88Ambiguous0.00.37Likely Benign0.63Ambiguous1.05Destabilizing-2.69Deleterious0.992Probably Damaging0.603Possibly Damaging3.43Benign0.06Tolerated3.3828320.0-14.03237.216.50.00.0-0.30.1XPotentially PathogenicThe carboxylate group of Glu666, located on the α-helix (res. Ser641-Glu666), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), such as Lys566, Thr672, and Asn669, in the WT simulations. In the variant simulations, the shorter side chain of Asp666 cannot maintain these interactions as efficiently as Glu666 in the WT, resulting in a less coordinated hydrogen-bond network.
c.2443C>GR815GSH3-binding motifUncertain 1-7.983In-Between0.854Likely PathogenicAmbiguous0.146Likely Benign-3.22Deleterious0.999Probably Damaging0.997Probably Damaging2.62Benign0.02Affected4.324-3-24.1-99.14
c.2443C>TR815CLikely PathogenicSH3-binding motifUncertain 16-33442995-C-T53.10e-6-9.373Likely Pathogenic0.828Likely PathogenicAmbiguous0.174Likely Benign-3.89Deleterious1.000Probably Damaging0.998Probably Damaging2.59Benign0.00Affected4.324-4-37.0-53.05
c.2444G>TR815LLikely PathogenicSH3-binding motifUncertain 1-8.546Likely Pathogenic0.865Likely PathogenicAmbiguous0.175Likely Benign-3.06Deleterious0.999Probably Damaging0.997Probably Damaging2.63Benign0.03Affected4.324-2-38.3-43.03
c.2458T>AY820NUncertain 1-9.032Likely Pathogenic0.842Likely PathogenicAmbiguous0.143Likely Benign-1.53Neutral0.999Probably Damaging0.977Probably Damaging2.74Benign0.20Tolerated-2-2-2.2-49.07
c.2459A>GY820CLikely PathogenicUncertain 1-8.797Likely Pathogenic0.744Likely PathogenicLikely Benign0.113Likely Benign-3.16Deleterious1.000Probably Damaging0.983Probably Damaging2.68Benign0.06Tolerated3.7750-23.8-60.04
c.2474C>TS825LLikely PathogenicUncertain 16-33443026-C-T16.20e-7-4.987Likely Benign0.910Likely PathogenicAmbiguous0.249Likely Benign-4.30Deleterious0.999Probably Damaging0.994Probably Damaging1.94Pathogenic0.01Affected3.775-2-34.626.08
c.2493G>CE831DLikely BenignUncertain 16-33443045-G-C16.19e-7-3.055Likely Benign0.063Likely BenignLikely Benign0.073Likely Benign1.23Neutral0.002Benign0.002Benign2.64Benign0.77Tolerated3.775320.0-14.03
c.2015C>AT672K
(3D Viewer)
Likely PathogenicGAPUncertain 1-12.192Likely Pathogenic0.698Likely PathogenicLikely Benign0.065Likely Benign0.20Likely Benign0.51.21Ambiguous0.71Ambiguous0.72Ambiguous-4.31Deleterious0.745Possibly Damaging0.051Benign3.40Benign0.07Tolerated3.40250-1-3.227.07195.17.00.40.70.40.1XXPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. In the variant simulations, Lys672 can only form a hydrogen bond with the amino group of the Lys566 side chain via its backbone carbonyl group. Consequently, it cannot maintain the Lys566-Glu666 salt bridge through hydrogen bonding. However, the amino group of Lys periodically forms a salt bridge with the carboxylate group of Glu666, which prevents a drastic disruption of the hydrogen-bond network that keeps the loop close to the helices.
c.2047A>GI683V
(3D Viewer)
Likely BenignGAPUncertain 16-33441306-A-G21.24e-6-7.588In-Between0.138Likely BenignLikely Benign0.112Likely Benign0.90Ambiguous0.00.60Ambiguous0.75Ambiguous0.76Ambiguous-0.78Neutral0.538Possibly Damaging0.080Benign3.35Benign0.14Tolerated3.421743-0.3-14.03215.629.10.00.0-0.70.1XPotentially BenignThe sec-butyl side chain of Ile683, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is sterically packed against His453 and Glu688. In the variant simulations, the iso-propyl side chain of Val683 has similar size and physicochemical properties as Ile630 in the WT, and thus, it is able to maintain similar interactions in the inter-helix space. Consequently, no negative structural effects are observed during the simulations due to the residue swap.
c.249A>TR83SLikely BenignUncertain 1-2.550Likely Benign0.999Likely PathogenicLikely Pathogenic0.094Likely Benign-1.87Neutral0.909Possibly Damaging0.587Possibly Damaging3.19Benign0.00Affected4.3210-13.7-69.11
c.2502G>CM834ILikely BenignUncertain 1-3.377Likely Benign0.291Likely BenignLikely Benign0.055Likely Benign-1.21Neutral0.026Benign0.009Benign2.56Benign0.00Affected4.324122.6-18.03
c.2506A>GS836GLikely BenignUncertain 16-33443058-A-G42.48e-6-4.749Likely Benign0.112Likely BenignLikely Benign0.066Likely Benign-1.65Neutral0.006Benign0.019Benign2.54Benign0.39Tolerated3.775100.4-30.03
c.250C>GR84GUncertain 1-6.627Likely Benign0.989Likely PathogenicLikely Pathogenic0.139Likely Benign-2.64Deleterious0.962Probably Damaging0.726Possibly Damaging3.68Benign0.00Affected4.321-3-24.1-99.14
c.2514C>AN838KLikely PathogenicUncertain 2-8.470Likely Pathogenic0.862Likely PathogenicAmbiguous0.097Likely Benign-2.78Deleterious0.997Probably Damaging0.995Probably Damaging2.69Benign0.16Tolerated3.77510-0.414.07
c.2518A>TS840CLikely PathogenicUncertain 1-8.799Likely Pathogenic0.904Likely PathogenicAmbiguous0.376Likely Benign-3.96Deleterious0.999Probably Damaging0.975Probably Damaging1.50Pathogenic0.00Affected3.7750-13.316.06
c.2521G>AV841MUncertain 16-33443073-G-A31.86e-6-7.000In-Between0.651Likely PathogenicLikely Benign0.119Likely Benign-0.74Neutral0.999Probably Damaging0.998Probably Damaging2.54Benign0.02Affected3.77512-2.332.06
c.2068T>CS690P
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.568Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.431Likely Benign4.84Destabilizing0.34.40Destabilizing4.62Destabilizing1.42Destabilizing-4.77Deleterious0.998Probably Damaging0.790Possibly Damaging3.44Benign0.01Affected3.42171-1-0.810.04207.515.10.10.0-0.10.2XXPotentially PathogenicThe hydroxyl side chain of Ser690, located in an α-helix (res. Leu696-Leu685), forms a hydrogen bond with the backbone carbonyl group of Ser410 in an anti-parallel β-sheet of the C2 domain (res. Ile411-Ala399). In the variant simulations, the pyrrolidine side chain of Pro690 cannot form hydrogen bonds with the C2 domain residue, resulting in the loss of this inter-domain connection. Additionally, prolines lack a free amide group necessary for hydrogen bonding with the carbonyl group of Gly686, introducing a slight bend in the α-helix and compromising its integrity.
c.2075T>CL692P
(3D Viewer)
Likely PathogenicGAPUncertain 1-16.447Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.668Likely Pathogenic9.19Destabilizing0.113.20Destabilizing11.20Destabilizing1.69Destabilizing-6.98Deleterious1.000Probably Damaging0.999Probably Damaging3.06Benign0.00Affected3.4217-3-3-5.4-16.04186.262.8-0.20.1-0.70.3XPotentially PathogenicThe isobutyl side chain of Leu692, located in the middle of an α-helix (res. Leu685-Gln702), engages in hydrophobic packing with nearby residues (e.g., Leu441, Leu431, Leu696) in the inter-helix space. Prolines lack a free amide group necessary for hydrogen bonding with the carbonyl group of Glu688 in the same manner as Leu692 in the WT. Consequently, the residue swap with proline disrupts the continuity of the secondary structure element in the variant simulations. Additionally, the side chain of Pro692 is not as optimal as Leu692 for hydrophobic packing in the inter-helix space.
c.2522T>CV841AUncertain 16-33443074-T-C31.86e-6-8.152Likely Pathogenic0.901Likely PathogenicAmbiguous0.183Likely Benign-2.13Neutral0.992Probably Damaging0.989Probably Damaging2.57Benign0.02Affected3.77500-2.4-28.05
c.2548G>AG850RLikely BenignUncertain 1-5.082Likely Benign0.398AmbiguousLikely Benign0.194Likely Benign-0.07Neutral0.010Benign0.010Benign4.30Benign0.01Affected3.775-3-2-4.199.14
c.2557G>CG853RLikely BenignUncertain 1-4.749Likely Benign0.366AmbiguousLikely Benign0.091Likely Benign-1.27Neutral0.846Possibly Damaging0.624Possibly Damaging4.18Benign0.00Affected-3-2-4.199.14
c.2560C>TR854CLikely BenignUncertain 16-33443112-C-T31.86e-6-5.082Likely Benign0.170Likely BenignLikely Benign0.174Likely Benign-2.48Neutral1.000Probably Damaging0.947Probably Damaging4.05Benign0.01Affected3.883-3-47.0-53.05
c.2561G>AR854HLikely BenignUncertain 16-33443113-G-A42.48e-6-3.686Likely Benign0.094Likely BenignLikely Benign0.183Likely Benign-1.38Neutral0.997Probably Damaging0.899Possibly Damaging4.07Benign0.04Affected3.883201.3-19.05
c.2567A>GN856SLikely BenignUncertain 16-33443119-A-G21.24e-6-2.104Likely Benign0.064Likely BenignLikely Benign0.040Likely Benign-1.54Neutral0.901Possibly Damaging0.535Possibly Damaging4.16Benign0.30Tolerated3.883112.7-27.03
c.256G>AV86ILikely BenignUncertain 1-4.726Likely Benign0.338Likely BenignLikely Benign0.076Likely Benign-0.31Neutral0.267Benign0.097Benign3.94Benign0.00Affected4.321430.314.03
c.2573G>AS858NLikely BenignUncertain 16-33443125-G-A21.24e-6-4.311Likely Benign0.121Likely BenignLikely Benign0.107Likely Benign-0.67Neutral0.448Benign0.846Possibly Damaging4.13Benign0.02Affected3.77511-2.727.03
c.2582C>TS861LLikely BenignUncertain 16-33443134-C-T21.24e-6-4.966Likely Benign0.219Likely BenignLikely Benign0.144Likely Benign-2.10Neutral0.904Possibly Damaging0.355Benign3.93Benign0.07Tolerated4.323-3-24.626.08
c.2105A>GQ702R
(3D Viewer)
GAPUncertain 1-7.894In-Between0.348AmbiguousLikely Benign0.294Likely Benign-0.31Likely Benign0.10.63Ambiguous0.16Likely Benign0.13Likely Benign-3.14Deleterious0.909Possibly Damaging0.889Possibly Damaging3.43Benign0.02Affected3.471011-1.028.06270.3-52.90.00.00.00.1XPotentially PathogenicThe carboxamide side chain of Gln702 is located at the end and outer surface of an α-helix (res. Leu685-Gln702), where it does not directly form hydrogen bonds with any residues in the WT simulations. In the variant simulations, the positively charged guanidinium group of Arg702 forms a salt bridge with the negatively charged carboxylate group of Glu698 on the same helix and/or hydrogen bonds with the backbone carbonyl group of Ala438 on an opposite α-helix (res. Tyr428-Glu436). Consequently, the residue swap could strengthen the tertiary structure assembly, which could have either positive or negative effects on its function.
c.2116G>AE706K
(3D Viewer)
GAPUncertain 1-10.519Likely Pathogenic0.833Likely PathogenicAmbiguous0.080Likely Benign1.17Ambiguous0.10.51Ambiguous0.84Ambiguous0.08Likely Benign-1.51Neutral0.345Benign0.028Benign4.15Benign0.52Tolerated3.471001-0.4-0.94187.149.20.00.00.40.1XUncertainThe carboxylate side chain of Glu706, located at the end and outer surface of an α-helix (res. Thr704-Gly712), forms a salt bridge with Lys710 and a hydrogen bond with its own backbone amino group at the helix end in the WT simulations. Although Lys706 is unable to make these transient interactions in the variant simulations, there is no apparent negative effect on the protein structure due to the residue swap. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2162T>GI721S
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.032Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.466Likely Benign3.91Destabilizing0.13.96Destabilizing3.94Destabilizing2.28Destabilizing-5.26Deleterious1.000Probably Damaging1.000Probably Damaging2.21Pathogenic0.00Affected3.509-1-2-5.3-26.08203.349.3-0.10.0-1.10.0XUncertainThe sec-butyl side chain of Ile721, located on an α-helix (res. Leu714-Arg726), engages in hydrophobic packing with other residues in the hydrophobic inter-helix space, such as Phe420, Tyr417, His693, and Leu717. In the variant simulations, the hydroxyl side chain of Ser721 forms hydrogen bonds with nearby residues, such as Leu717 and His693. Although no major structural changes are observed during the variant simulations, the hydrophilic residue Ser721 could disrupt the hydrophobic packing during folding. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2591C>TA864VLikely BenignUncertain 26-33443143-C-T63.72e-6-4.749Likely Benign0.126Likely BenignLikely Benign0.038Likely Benign-1.35Neutral0.767Possibly Damaging0.119Benign2.45Pathogenic0.30Tolerated3.824002.428.05
c.2596G>TV866LLikely BenignUncertain 16-33443148-G-T16.20e-7-3.352Likely Benign0.148Likely BenignLikely Benign0.046Likely Benign-0.97Neutral0.217Benign0.229Benign2.71Benign0.21Tolerated3.82421-0.414.03
c.2608C>GL870VLikely BenignUncertain 1-4.123Likely Benign0.300Likely BenignLikely Benign0.111Likely Benign-1.19Neutral0.997Probably Damaging0.992Probably Damaging2.64Benign0.12Tolerated3.883210.4-14.03
c.2619C>GS873RUncertain 16-33443171-C-G16.20e-7-5.856Likely Benign0.976Likely PathogenicLikely Pathogenic0.192Likely Benign-2.74Deleterious0.997Probably Damaging0.995Probably Damaging2.67Benign0.06Tolerated3.7750-1-3.769.11
c.2623G>AA875TLikely BenignUncertain 16-33443175-G-A16.20e-7-3.793Likely Benign0.179Likely BenignLikely Benign0.110Likely Benign-1.56Neutral0.972Probably Damaging0.864Possibly Damaging2.72Benign0.26Tolerated3.77501-2.530.03
c.2627C>TS876LUncertain 2-5.856Likely Benign0.489AmbiguousLikely Benign0.249Likely Benign-3.56Deleterious0.998Probably Damaging0.992Probably Damaging2.57Benign0.05Affected3.775-2-34.626.08
c.2632A>GT878ALikely BenignUncertain 1-2.154Likely Benign0.081Likely BenignLikely Benign0.088Likely Benign-0.67Neutral0.003Benign0.006Benign2.73Benign0.18Tolerated3.775102.5-30.03
c.263T>CV88ALikely BenignUncertain 1-5.860Likely Benign0.993Likely PathogenicLikely Pathogenic0.050Likely Benign-1.22Neutral0.053Benign0.008Benign3.75Benign0.00Affected4.32100-2.4-28.05
c.2650C>TR884WLikely BenignUncertain 16-33443202-C-T53.10e-6-3.785Likely Benign0.332Likely BenignLikely Benign0.151Likely Benign0.26Neutral0.995Probably Damaging0.812Possibly Damaging2.56Benign0.05Affected4.324-323.630.03
c.2651G>AR884QLikely BenignUncertain 26-33443203-G-A53.10e-6-3.785Likely Benign0.128Likely BenignLikely Benign0.055Likely Benign-0.42Neutral0.012Benign0.004Benign2.62Benign0.36Tolerated4.324111.0-28.06
c.2657C>TA886VLikely BenignUncertain 16-33443209-C-T181.12e-5-4.478Likely Benign0.078Likely BenignLikely Benign0.061Likely Benign-0.20Neutral0.888Possibly Damaging0.314Benign2.17Pathogenic0.00Affected4.324002.428.05
c.265C>GP89ALikely BenignUncertain 2-5.778Likely Benign0.920Likely PathogenicAmbiguous0.095Likely Benign-2.47Neutral0.225Benign0.020Benign3.77Benign0.00Affected4.3211-13.4-26.04
c.266C>TP89LUncertain 2-6.775Likely Benign0.982Likely PathogenicLikely Pathogenic0.119Likely Benign-3.29Deleterious0.889Possibly Damaging0.058Benign3.73Benign0.00Affected4.321-3-35.416.04
c.2681G>AG894ELikely BenignUncertain 16-33443233-G-A63.72e-6-5.377Likely Benign0.859Likely PathogenicAmbiguous0.180Likely Benign-2.07Neutral1.000Probably Damaging1.000Probably Damaging2.68Benign0.01Affected4.3240-2-3.172.06
c.2684G>AS895NLikely BenignUncertain 1-6.399Likely Benign0.604Likely PathogenicLikely Benign0.118Likely Benign-0.85Neutral0.991Probably Damaging0.988Probably Damaging2.64Benign0.30Tolerated4.32411-2.727.03
c.2690C>TS897LLikely BenignUncertain 1-4.034Likely Benign0.299Likely BenignLikely Benign0.028Likely Benign-1.71Neutral0.901Possibly Damaging0.636Possibly Damaging2.66Benign0.01Affected-3-24.626.08
c.269T>AV90ELikely BenignUncertain 1-4.079Likely Benign0.703Likely PathogenicLikely Benign0.108Likely Benign-0.38Neutral0.001Benign0.000Benign4.00Benign0.00Affected4.321-2-2-7.729.98
c.2702C>TA901VLikely BenignUncertain 26-33443254-C-T21.24e-6-5.043Likely Benign0.219Likely BenignLikely Benign0.029Likely Benign-1.83Neutral0.106Benign0.009Benign2.64Benign0.17Tolerated3.775002.428.05
c.2711T>CM904TLikely BenignUncertain 1-2.721Likely Benign0.668Likely PathogenicLikely Benign0.042Likely Benign-1.15Neutral0.277Benign0.103Benign2.78Benign0.18Tolerated3.775-1-1-2.6-30.09
c.2714G>AR905HLikely BenignUncertain 16-33443266-G-A84.96e-6-4.182Likely Benign0.457AmbiguousLikely Benign0.192Likely Benign-1.11Neutral1.000Probably Damaging0.991Probably Damaging2.59Benign0.09Tolerated3.775201.3-19.05
c.2729G>CG910ALikely BenignUncertain 16-33443281-G-C16.20e-7-3.587Likely Benign0.361AmbiguousLikely Benign0.209Likely Benign-1.43Neutral0.999Probably Damaging0.999Probably Damaging2.78Benign0.10Tolerated3.775102.214.03
c.2735C>AT912NLikely BenignUncertain 1-4.260Likely Benign0.190Likely BenignLikely Benign0.116Likely Benign-1.15Neutral0.999Probably Damaging0.977Probably Damaging3.96Benign0.00Affected3.77500-2.813.00
c.2741A>TD914VLikely BenignUncertain 1-4.260Likely Benign0.723Likely PathogenicLikely Benign0.187Likely Benign-2.24Neutral0.999Probably Damaging0.986Probably Damaging2.64Benign0.01Affected3.775-3-27.7-15.96
c.2750C>GP917RLikely BenignUncertain 16-33443302-C-G53.10e-6-4.475Likely Benign0.363AmbiguousLikely Benign0.142Likely Benign-1.70Neutral0.642Possibly Damaging0.316Benign2.68Benign0.00Affected3.775-20-2.959.07
c.2752G>AA918TLikely BenignUncertain 16-33443304-G-A16.20e-7-4.139Likely Benign0.083Likely BenignLikely Benign0.065Likely Benign-1.09Neutral0.980Probably Damaging0.721Possibly Damaging2.64Benign0.03Affected4.32401-2.530.03
c.2753C>TA918VLikely BenignUncertain 36-33443305-C-T21.24e-6-3.684Likely Benign0.112Likely BenignLikely Benign0.119Likely Benign-1.61Neutral0.980Probably Damaging0.782Possibly Damaging2.61Benign0.03Affected4.324002.428.05
c.2768T>AI923NLikely BenignUncertain 1-0.733Likely Benign0.712Likely PathogenicLikely Benign0.108Likely Benign-1.16Neutral0.991Probably Damaging0.793Possibly Damaging2.70Benign0.13Tolerated3.775-2-3-8.00.94
c.277C>GR93GLikely BenignUncertain 1-2.674Likely Benign0.400AmbiguousLikely Benign0.093Likely Benign-1.69Neutral0.103Benign0.019Benign3.99Benign0.00Affected4.321-2-34.1-99.14
c.2809G>CD937HLikely BenignUncertain 1-0.733Likely Benign0.677Likely PathogenicLikely Benign0.150Likely Benign-1.74Neutral1.000Probably Damaging0.975Probably Damaging2.68Benign0.13Tolerated3.775-110.322.05
c.2812G>AG938RLikely BenignUncertain 1-5.271Likely Benign0.732Likely PathogenicLikely Benign0.141Likely Benign-1.11Neutral0.999Probably Damaging0.985Probably Damaging2.74Benign0.36Tolerated3.775-3-2-4.199.14
c.2818G>AG940SLikely BenignUncertain 16-33443370-G-A16.20e-7-5.451Likely Benign0.084Likely BenignLikely Benign0.135Likely Benign0.45Neutral0.409Benign0.253Benign2.77Benign0.44Tolerated3.77510-0.430.03
c.2822C>TP941LLikely BenignUncertain 2-5.692Likely Benign0.066Likely BenignLikely Benign0.054Likely Benign-0.44Neutral0.144Benign0.039Benign2.76Benign0.01Affected-3-35.416.04
c.2825C>TP942LLikely BenignUncertain 16-33443377-C-T42.48e-6-5.063Likely Benign0.086Likely BenignLikely Benign0.048Likely Benign-2.00Neutral0.411Benign0.239Benign2.37Pathogenic0.00Affected4.324-3-35.416.04
c.2855G>TG952VLikely BenignUncertain 1-7.074In-Between0.078Likely BenignLikely Benign0.231Likely Benign-0.33Neutral0.000Benign0.000Benign3.20Benign0.02Affected3.775-1-34.642.08
c.2858C>AP953QLikely BenignUncertain 1-6.038Likely Benign0.079Likely BenignLikely Benign0.086Likely Benign-0.78Neutral0.058Benign0.015Benign2.78Benign0.29Tolerated3.7750-1-1.931.01
c.2863T>CS955PLikely BenignUncertain 16-33443415-T-C31.86e-6-2.584Likely Benign0.073Likely BenignLikely Benign0.098Likely Benign-0.75Neutral0.001Benign0.004Benign2.33Pathogenic0.00Affected3.7751-1-0.810.04
c.286G>AG96SLikely BenignUncertain 16-33425894-G-A53.10e-6-3.049Likely Benign0.065Likely BenignLikely Benign0.071Likely Benign-0.76Neutral0.364Benign0.008Benign4.25Benign0.00Affected4.32110-0.430.03
c.2888A>GH963RLikely BenignUncertain 16-33443440-A-G84.96e-6-8.952Likely Pathogenic0.169Likely BenignLikely Benign0.081Likely Benign-1.28Neutral0.001Benign0.003Benign4.15Benign0.24Tolerated3.77520-1.319.05
c.28C>TR10WLikely BenignUncertain 16-33420292-C-T21.30e-6-5.707Likely Benign0.503AmbiguousLikely Benign0.236Likely Benign-0.31Neutral0.964Probably Damaging0.190Benign4.10Benign0.00Affected4.3212-33.630.03
c.2900G>TR967LLikely BenignUncertain 16-33443452-G-T16.20e-7-3.496Likely Benign0.164Likely BenignLikely Benign0.123Likely Benign-0.99Neutral0.959Probably Damaging0.586Possibly Damaging4.15Benign0.75Tolerated4.322-2-38.3-43.03
c.2912C>AP971HLikely BenignUncertain 16-33443464-C-A16.20e-7-5.243Likely Benign0.086Likely BenignLikely Benign0.039Likely Benign-1.11Neutral0.898Possibly Damaging0.477Possibly Damaging3.89Benign0.00Affected4.322-20-1.640.02
c.2914C>GP972ALikely BenignUncertain 16-33443466-C-G16.20e-7-0.167Likely Benign0.045Likely BenignLikely Benign0.046Likely Benign-0.89Neutral0.016Benign0.011Benign4.29Benign0.07Tolerated4.322-113.4-26.04
c.2914C>TP972SLikely BenignUncertain 16-33443466-C-T42.48e-6-4.008Likely Benign0.058Likely BenignLikely Benign0.074Likely Benign-0.38Neutral0.001Benign0.002Benign4.28Benign0.05Affected4.322-110.8-10.04
c.291G>TE97DLikely BenignUncertain 36-33425899-G-T-3.239Likely Benign0.077Likely BenignLikely Benign0.081Likely Benign-0.49Neutral0.880Possibly Damaging0.636Possibly Damaging4.12Benign0.00Affected4.321320.0-14.03
c.2924C>AT975NLikely BenignUncertain 16-33443476-C-A16.20e-7-4.671Likely Benign0.089Likely BenignLikely Benign0.100Likely Benign-0.58Neutral0.586Possibly Damaging0.302Benign4.13Benign0.07Tolerated4.32200-2.813.00
c.2924C>GT975SLikely BenignUncertain 1-2.743Likely Benign0.068Likely BenignLikely Benign0.109Likely Benign-0.57Neutral0.059Benign0.061Benign4.16Benign0.20Tolerated11-0.1-14.03
c.2924C>TT975ILikely BenignUncertain 16-33443476-C-T63.72e-6-3.912Likely Benign0.164Likely BenignLikely Benign0.068Likely Benign-1.66Neutral0.411Benign0.239Benign4.11Benign0.66Tolerated4.3220-15.212.05
c.2928T>GF976LLikely BenignUncertain 1-2.432Likely Benign0.825Likely PathogenicAmbiguous0.212Likely Benign-0.87Neutral0.264Benign0.102Benign4.20Benign0.53Tolerated4.322201.0-34.02
c.2932C>TP978SLikely BenignUncertain 1-3.913Likely Benign0.151Likely BenignLikely Benign0.085Likely Benign-1.07Neutral0.481Possibly Damaging0.220Benign4.22Benign0.48Tolerated1-10.8-10.04
c.2935T>CF979LLikely BenignUncertain 1-2.341Likely Benign0.870Likely PathogenicAmbiguous0.228Likely Benign-1.00Neutral0.625Possibly Damaging0.430Benign4.22Benign0.73Tolerated4.322201.0-34.02
c.2954G>AS985NLikely BenignUncertain 1-6.979Likely Benign0.845Likely PathogenicAmbiguous0.088Likely Benign-1.68Neutral0.991Probably Damaging0.988Probably Damaging2.65Benign0.00Affected4.32111-2.727.03
c.2960A>GD987GLikely PathogenicUncertain 1-4.782Likely Benign0.849Likely PathogenicAmbiguous0.234Likely Benign-2.79Deleterious0.943Possibly Damaging0.808Possibly Damaging2.45Pathogenic0.07Tolerated4.3221-13.1-58.04
c.2962C>TL988FLikely BenignUncertain 16-33443514-C-T16.20e-7-4.368Likely Benign0.356AmbiguousLikely Benign0.135Likely Benign-1.70Neutral0.977Probably Damaging0.900Possibly Damaging2.69Benign0.00Affected4.32220-1.034.02
c.2983C>TP995SLikely BenignUncertain 1-4.457Likely Benign0.071Likely BenignLikely Benign0.042Likely Benign-1.03Neutral0.011Benign0.015Benign4.24Benign0.00Affected4.3211-10.8-10.04
c.2989G>AA997TLikely BenignUncertain 1-4.102Likely Benign0.071Likely BenignLikely Benign0.085Likely Benign-0.62Neutral0.224Benign0.120Benign4.17Benign0.00Affected4.32410-2.530.03
c.2998A>GI1000VLikely BenignUncertain 2-4.102Likely Benign0.098Likely BenignLikely Benign0.086Likely Benign-0.20Neutral0.437Benign0.170Benign2.76Benign0.81Tolerated4.32434-0.3-14.03
c.29G>AR10QLikely BenignUncertain 26-33420293-G-A201.30e-5-4.438Likely Benign0.185Likely BenignLikely Benign0.084Likely Benign0.03Neutral0.121Benign0.004Benign4.17Benign0.00Affected4.321111.0-28.06
c.29G>CR10PLikely BenignUncertain 26-33420293-G-C21.30e-6-3.772Likely Benign0.162Likely BenignLikely Benign0.220Likely Benign-0.05Neutral0.233Benign0.026Benign4.13Benign0.00Affected4.3210-22.9-59.07
c.3002T>CL1001PLikely BenignUncertain 1-3.071Likely Benign0.209Likely BenignLikely Benign0.113Likely Benign-1.02Neutral0.966Probably Damaging0.690Possibly Damaging2.65Benign0.00Affected4.324-3-3-5.4-16.04
c.3009C>GS1003RUncertain 1-5.113Likely Benign0.991Likely PathogenicLikely Pathogenic0.141Likely Benign-1.88Neutral0.999Probably Damaging0.996Probably Damaging2.48Pathogenic0.00Affected3.7750-1-3.769.11
c.3023A>GD1008GUncertain 16-33443575-A-G16.20e-7-3.213Likely Benign0.742Likely PathogenicLikely Benign0.203Likely Benign-2.84Deleterious0.999Probably Damaging0.997Probably Damaging2.65Benign0.01Affected3.775-113.1-58.04
c.3026A>CE1009ALikely PathogenicUncertain 1-3.118Likely Benign0.679Likely PathogenicLikely Benign0.109Likely Benign-3.06Deleterious0.980Probably Damaging0.630Possibly Damaging2.39Pathogenic0.01Affected3.7750-15.3-58.04
c.3038C>GS1013CLikely BenignUncertain 16-33443590-C-G42.48e-6-6.745Likely Benign0.110Likely BenignLikely Benign0.058Likely Benign-2.06Neutral0.898Possibly Damaging0.579Possibly Damaging2.64Benign0.05Affected3.7750-13.316.06
c.303C>AH101QLikely BenignUncertain 16-33432168-C-A16.20e-7-2.827Likely Benign0.124Likely BenignLikely Benign0.147Likely Benign-0.37Neutral0.824Possibly Damaging0.880Possibly Damaging4.24Benign0.00Affected4.32130-0.3-9.01
c.3041G>TG1014VLikely BenignUncertain 1-4.612Likely Benign0.181Likely BenignLikely Benign0.053Likely Benign-2.47Neutral0.818Possibly Damaging0.377Benign2.72Benign0.06Tolerated3.775-1-34.642.08
c.304T>GL102VLikely BenignUncertain 16-33432169-T-G16.20e-7-4.316Likely Benign0.068Likely BenignLikely Benign0.102Likely Benign0.32Neutral0.880Possibly Damaging0.899Possibly Damaging4.21Benign0.00Affected4.321210.4-14.03
c.3053C>TT1018IUncertain 16-33443605-C-T42.48e-6-3.264Likely Benign0.524AmbiguousLikely Benign0.076Likely Benign-2.55Deleterious0.586Possibly Damaging0.304Benign2.24Pathogenic0.01Affected3.775-105.212.05
c.3056G>TR1019LLikely PathogenicUncertain 16-33443608-G-T21.24e-6-5.194Likely Benign0.752Likely PathogenicLikely Benign0.110Likely Benign-3.57Deleterious0.800Possibly Damaging0.573Possibly Damaging2.40Pathogenic0.01Affected3.775-2-38.3-43.03
c.3059G>CR1020PLikely PathogenicUncertain 1-3.491Likely Benign0.902Likely PathogenicAmbiguous0.205Likely Benign-3.50Deleterious0.999Probably Damaging0.977Probably Damaging2.46Pathogenic0.00Affected0-22.9-59.07
c.3059G>TR1020LUncertain 1-6.031Likely Benign0.907Likely PathogenicAmbiguous0.216Likely Benign-4.03Deleterious0.990Probably Damaging0.921Probably Damaging2.50Benign0.00Affected3.775-3-28.3-43.03
c.3092T>CM1031TLikely BenignUncertain 16-33443644-T-C21.24e-6-1.863Likely Benign0.540AmbiguousLikely Benign0.085Likely Benign-0.24Neutral0.002Benign0.005Benign2.67Benign1.00Tolerated3.775-1-1-2.6-30.09
c.3103C>AP1035TLikely BenignUncertain 1-4.447Likely Benign0.426AmbiguousLikely Benign0.087Likely Benign-0.96Neutral0.901Possibly Damaging0.537Possibly Damaging2.72Benign0.23Tolerated3.7750-10.93.99
c.3116T>CI1039TLikely BenignUncertain 16-33443668-T-C127.43e-6-2.465Likely Benign0.645Likely PathogenicLikely Benign0.193Likely Benign0.45Neutral0.004Benign0.008Benign2.75Benign0.10Tolerated3.775-10-5.2-12.05
c.3119G>TG1040VLikely PathogenicUncertain 16-33443671-G-T42.48e-6-3.453Likely Benign0.645Likely PathogenicLikely Benign0.774Likely Pathogenic-2.89Deleterious0.827Possibly Damaging0.456Possibly Damaging-0.74Pathogenic0.01Affected3.775-1-34.642.08
c.3125A>GQ1042RLikely BenignUncertain 26-33443677-A-G21.24e-6-2.928Likely Benign0.413AmbiguousLikely Benign0.300Likely Benign-1.39Neutral0.586Possibly Damaging0.120Benign5.48Benign0.12Tolerated3.77511-1.028.06
c.3136C>GP1046ALikely BenignUncertain 16-33443688-C-G16.20e-7-3.246Likely Benign0.048Likely BenignLikely Benign0.041Likely Benign-1.67Neutral0.001Benign0.008Benign2.39Pathogenic0.29Tolerated3.775-113.4-26.04
c.313T>CS105PLikely BenignUncertain 1-3.631Likely Benign0.166Likely BenignLikely Benign0.204Likely Benign0.03Neutral0.808Possibly Damaging0.212Benign4.00Benign0.00Affected4.321-11-0.810.04
c.3142G>CG1048RLikely BenignUncertain 1-4.305Likely Benign0.435AmbiguousLikely Benign0.503Likely Pathogenic-0.54Neutral0.919Possibly Damaging0.728Possibly Damaging2.54Benign0.10Tolerated3.775-2-3-4.199.14
c.314C>TS105LLikely BenignUncertain 26-33432179-C-T42.48e-6-3.710Likely Benign0.233Likely BenignLikely Benign0.095Likely Benign-1.52Neutral0.828Possibly Damaging0.048Benign4.06Benign0.00Affected4.321-3-24.626.08
c.3154G>AG1052RUncertain 1-9.050Likely Pathogenic0.383AmbiguousLikely Benign0.497Likely Benign-0.41Neutral0.990Probably Damaging0.798Possibly Damaging3.90Benign0.10Tolerated3.775-2-3-4.199.14
c.3161G>AG1054DUncertain 1-10.385Likely Pathogenic0.351AmbiguousLikely Benign0.279Likely Benign-0.26Neutral0.818Possibly Damaging0.266Benign4.07Benign0.37Tolerated3.7751-1-3.158.04
c.3170G>AS1057NLikely BenignUncertain 1-6.386Likely Benign0.117Likely BenignLikely Benign0.218Likely Benign-0.41Neutral0.451Benign0.129Benign5.25Benign0.28Tolerated11-2.727.03
c.3175G>AG1059RUncertain 16-33443727-G-A684.23e-5-8.452Likely Pathogenic0.376AmbiguousLikely Benign0.333Likely Benign-0.55Neutral0.001Benign0.001Benign2.53Benign0.00Affected4.322-3-2-4.199.14
c.3176G>CG1059ALikely BenignUncertain 16-33443728-G-C42.49e-6-6.754Likely Benign0.081Likely BenignLikely Benign0.329Likely Benign-0.17Neutral0.001Benign0.002Benign2.56Benign0.00Affected4.322102.214.03
c.3178G>AG1060SLikely BenignUncertain 16-33443730-G-A-4.759Likely Benign0.082Likely BenignLikely Benign0.376Likely Benign-0.08Neutral0.271Benign0.054Benign2.69Benign0.49Tolerated4.32210-0.430.03
c.3181G>AG1061SLikely BenignUncertain 1-4.891Likely Benign0.079Likely BenignLikely Benign0.283Likely Benign-0.68Neutral0.004Benign0.004Benign4.00Benign0.00Affected10-0.430.03
c.3192G>CQ1064HLikely BenignUncertain 1-4.576Likely Benign0.162Likely BenignLikely Benign0.063Likely Benign-0.66Neutral0.938Possibly Damaging0.596Possibly Damaging4.15Benign0.05Affected300.39.01
c.3209_3210delinsCAR1070TLikely BenignUncertain 1-5.093Likely Benign0.860Likely PathogenicAmbiguous-2.35Neutral0.948Possibly Damaging0.507Possibly Damaging3.78Benign0.01Affected3.775-1-13.8-55.08
c.3223C>AQ1075KLikely BenignUncertain 1-5.135Likely Benign0.728Likely PathogenicLikely Benign0.134Likely Benign-0.67Neutral0.963Probably Damaging0.959Probably Damaging2.75Benign1.00Tolerated3.77511-0.40.04
c.3233T>AV1078DLikely BenignUncertain 1-5.155Likely Benign0.979Likely PathogenicLikely Pathogenic0.158Likely Benign-1.45Neutral0.003Benign0.008Benign3.84Benign0.00Affected3.775-3-2-7.715.96
c.3237C>AS1079RLikely BenignUncertain 16-33443789-C-A42.51e-6-4.579Likely Benign0.955Likely PathogenicAmbiguous0.123Likely Benign-1.81Neutral0.177Benign0.075Benign3.86Benign0.00Affected3.7750-1-3.769.11
c.3238G>TA1080SLikely BenignUncertain 16-33443790-G-T16.26e-7-3.277Likely Benign0.108Likely BenignLikely Benign0.103Likely Benign0.01Neutral0.702Possibly Damaging0.346Benign4.16Benign0.08Tolerated3.77511-2.616.00
c.323A>GK108RLikely BenignUncertain 16-33432188-A-G63.72e-6-2.892Likely Benign0.148Likely BenignLikely Benign0.184Likely Benign0.37Neutral0.993Probably Damaging0.956Probably Damaging4.22Benign1.00Tolerated3.61532-0.628.01
c.3250C>GP1084ALikely BenignUncertain 1-3.928Likely Benign0.066Likely BenignLikely Benign0.114Likely Benign-2.54Deleterious0.649Possibly Damaging0.157Benign4.05Benign0.35Tolerated3.775-113.4-26.04
c.3251C>AP1084HLikely BenignUncertain 16-33443803-C-A16.31e-7-4.125Likely Benign0.323Likely BenignLikely Benign0.134Likely Benign-3.16Deleterious0.997Probably Damaging0.840Possibly Damaging3.96Benign0.00Affected3.775-20-1.640.02
c.3253C>TR1085WUncertain 16-33443805-C-T21.26e-6-6.339Likely Benign0.821Likely PathogenicAmbiguous0.202Likely Benign-3.15Deleterious1.000Probably Damaging0.996Probably Damaging2.70Benign0.00Affected3.775-323.630.03
c.3254G>AR1085QLikely BenignUncertain 16-33443806-G-A53.16e-6-3.843Likely Benign0.589Likely PathogenicLikely Benign0.224Likely Benign-1.43Neutral0.998Probably Damaging0.988Probably Damaging2.73Benign0.02Affected3.775111.0-28.06
c.3260C>TS1087FUncertain 1-3.843Likely Benign0.497AmbiguousLikely Benign0.105Likely Benign-2.75Deleterious0.990Probably Damaging0.796Possibly Damaging2.56Benign0.03Affected3.775-2-33.660.10
c.3262A>GS1088GLikely BenignUncertain 1-5.034Likely Benign0.285Likely BenignLikely Benign0.163Likely Benign-1.83Neutral0.979Probably Damaging0.973Probably Damaging2.63Benign0.03Affected3.775010.4-30.03
c.3287A>CE1096ALikely BenignUncertain 1-4.504Likely Benign0.510AmbiguousLikely Benign0.164Likely Benign-1.37Neutral0.626Possibly Damaging0.184Benign2.77Benign0.16Tolerated3.775-105.3-58.04
c.3304G>AA1102TLikely BenignUncertain 16-33443856-G-A117.17e-6-3.540Likely Benign0.070Likely BenignLikely Benign0.044Likely Benign-0.30Neutral0.001Benign0.001Benign2.32Pathogenic0.95Tolerated3.77510-2.530.03
c.3304G>CA1102PLikely BenignUncertain 1-5.120Likely Benign0.077Likely BenignLikely Benign0.118Likely Benign-0.97Neutral0.000Benign0.002Benign2.26Pathogenic0.13Tolerated3.775-11-3.426.04
c.3307C>TR1103CUncertain 16-33443859-C-T63.92e-6-2.440Likely Benign0.246Likely BenignLikely Benign0.140Likely Benign-3.01Deleterious0.996Probably Damaging0.787Possibly Damaging2.41Pathogenic0.01Affected3.775-3-47.0-53.05

Found 757 rows. Show 200 rows per page. Page 3/4 |